x

VALIDOGEN News

101 31.01.2023

Meet us at  

Upcoming online conferences & exhibitions
→ Details
102 15.12.2021

Spotlight on VALIDOGEN’s strain and process development program

Spotlight on microbioreactors supporting Pichia protein production strain selection and bioreactor cultivation process development
→ Details
103 16.03.2021

VALIDOGEN to present at PICHIA 2021, online conference, March 24 - April 1

Pichia 2021, online conference "Don't miss latest insights into UNLOCK PICHIA technology developments"
→ Details
104 18.06.2020

New case study on VHH antibody expression underlines the power of UNLOCK PICHIA

We conducted a series of case studies, demonstrating the yield-enhancing effects of applying different toolbox elements of VALIDOGEN's Pichia ...
→ Details
105 05.06.2019

Spotlight on high-yield VHH expression using UNLOCK PICHIA

Benefit from the economic advantages of enhanced VHH production arising from the use of UNLOCK PICHIA
→ Details
106 22.10.2018

VTU Technology is now VALIDOGEN

VTU Technology is now VALIDOGEN
→ Details
107 26.06.2017

What About Pichia?  

Read our latest article "What about Pichia"  reviewing recent advances in optimising Pichia  European Biopharmaceutical Review July 2017, ...
→ Details
108 24.05.2016

Evercyte and VTU Technology collaborate on development of recombinant media supplements

Launch of first joint product – VEGF 165 for cell culture applications 
→ Details
109 27.04.2016

VTU Technology and Boehringer Ingelheim strengthen their global microbial technology collaboration

 
→ Details
110 19.04.2016

Pichia production of albumin fusion proteins  

→ Details
111 11.04.2016

VTU Technology and Biomay have signed license agreement

Biomay to apply VTU Pichia strains for the production of recombinant allergens  
→ Details
112 10.02.2015

Boehringer Ingelheim renews global technology collaboration agreement with VTU Technology

 
→ Details
113 03.12.2014

VTU Technology and RCT Announce Partnership

VTU Technology to offer unique combination of technologies for the high-level production of proteins with human-like glycosylation using Pichia ...
→ Details
114 04.07.2013

From Consulting Engineers to Technology Company

With more than 300 employees and 15 sites, VTU is now competing in the premier league of technology service providers.
→ Details
115 27.11.2012

VTU Technology and Minapharm Pharmaceuticals enter into development and license agreement

VTU Technology and Minapharm Pharmaceuticals announced today, that they have entered into a licensing agreement to develop a therapeutic, recombinant ...
→ Details
116 01.11.2012

VTU Technology featured in GEN - Genetic Engineering & Biotechnology News

→ Details
117 18.09.2012

DNA2.0 taps VTU Technology as Research Partner for Industrial Scale Protein Expression

DNA2.0 and VTU to Develop an Optimized Gene Design for Pichia Pastoris 
→ Details
118 04.01.2012

Almac and VTU Technology form collaboration - broader range of contract services

Almac and VTU Technology form collaboration to provide customers with high yielding, fast-track generation of site-specific modified products
→ Details
119 04.12.2011

VTU Technology Launches Breakthrough Technology for High Level Methanol-free Protein Expression

VTU Technology, a leading contract research and development company providing services for the fast-track generation of high-performance industrial ...
→ Details
120 20.11.2011

Collaboration of Boehringer Ingelheim and VTU Technology in Technology and Marketing

Boehringer Ingelheim, a global leader in biopharmaceutical contract development and manufacture, and VTU Technology, a leading supplier of exclusive ...
→ Details
X
KEEP in TOUCH
Sign up to our mailing list to keep up with latest developments and information around Pichia based protein expression.
GET in TOUCH
X
Welcome to VALIDOGEN!
Would you like us to contact you personally?
REQUEST NOW

News

Meet us at  

Upcoming online conferences & exhibitions
→ Details

Spotlight on VALIDOGEN’s strain and process development program

Spotlight on microbioreactors supporting Pichia protein production strain ...
→ Details

Press

Press center

→ Press Downloads

Downloads

Company folder and brochures

→ All downloads
Tablet Potrait-Mode gerade in Arbeit, bitte drehen Sie das Tablet in den Landscape-Mode.